These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8929745

  • 21. Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.
    Karachalias N, Babaei-Jadidi R, Rabbani N, Thornalley PJ.
    Diabetologia; 2010 Jul; 53(7):1506-16. PubMed ID: 20369223
    [Abstract] [Full Text] [Related]

  • 22. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose.
    Pomero F, Molinar Min A, La Selva M, Allione A, Molinatti GM, Porta M.
    Acta Diabetol; 2001 Jul; 38(3):135-8. PubMed ID: 11827434
    [Abstract] [Full Text] [Related]

  • 23. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
    Haupt E, Ledermann H, Köpcke W.
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875
    [Abstract] [Full Text] [Related]

  • 24. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V, Puozzo C.
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [Abstract] [Full Text] [Related]

  • 25. [The immunometaboic effects of benfotiamine and riboxine on hemolytic anemia].
    Uteshev BS, Lazareva GA, Prokopenko LG.
    Eksp Klin Farmakol; 2002 Sep; 65(4):37-41. PubMed ID: 12449073
    [Abstract] [Full Text] [Related]

  • 26. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
    Frank T, Bitsch R, Maiwald J, Stein G.
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):449-55. PubMed ID: 10507244
    [Abstract] [Full Text] [Related]

  • 27. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine.
    Beltramo E, Berrone E, Tarallo S, Porta M.
    Diabetes Metab Res Rev; 2009 Sep; 25(6):566-76. PubMed ID: 19593734
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W, Barth H, Osterloh G, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [Abstract] [Full Text] [Related]

  • 29. Protective effect of treatment with thiamine or benfotiamine on liver oxidative damage in rat model of acute ethanol intoxication.
    Portari GV, Ovidio PP, Deminice R, Jordão AA.
    Life Sci; 2016 Oct 01; 162():21-4. PubMed ID: 27545821
    [Abstract] [Full Text] [Related]

  • 30. Paraptosis cell death induction by the thiamine analog benfotiamine in leukemia cells.
    Sugimori N, Espinoza JL, Trung LQ, Takami A, Kondo Y, An DT, Sasaki M, Wakayama T, Nakao S.
    PLoS One; 2015 Oct 01; 10(4):e0120709. PubMed ID: 25849583
    [Abstract] [Full Text] [Related]

  • 31. 5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimens.
    Al Safarjalani ON, Zhou XJ, Rais RH, Shi J, Schinazi RF, Naguib FN, El Kouni MH.
    Cancer Chemother Pharmacol; 2005 Jun 01; 55(6):541-51. PubMed ID: 15729584
    [Abstract] [Full Text] [Related]

  • 32. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
    Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ.
    Diabetes; 2003 Aug 01; 52(8):2110-20. PubMed ID: 12882930
    [Abstract] [Full Text] [Related]

  • 33. Bioavailability of water- and lipid-soluble thiamin compounds in broiler chickens.
    Geyer J, Netzel M, Bitsch I, Frank T, Bitsch R, Krämer K, Hoppe PP.
    Int J Vitam Nutr Res; 2000 Dec 01; 70(6):311-6. PubMed ID: 11214357
    [Abstract] [Full Text] [Related]

  • 34. Antiglycation activity of thiamin-HCl and benfotiamine in diabetic condition.
    Kousar S, Sheikh MA, Asghar M.
    J Pak Med Assoc; 2012 Oct 01; 62(10):1033-8. PubMed ID: 23866441
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL, Salmon JH, Papich MG.
    Am J Vet Res; 2006 Jun 01; 67(6):1070-5. PubMed ID: 16740104
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of the transdermal delivery of benfotiamine.
    Zhu Z, Varadi G, Carter SG.
    Acta Diabetol; 2016 Apr 01; 53(2):317-22. PubMed ID: 26141141
    [Abstract] [Full Text] [Related]

  • 37. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
    Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.
    Nat Med; 2003 Mar 01; 9(3):294-9. PubMed ID: 12592403
    [Abstract] [Full Text] [Related]

  • 38. Absorption, kinetics, antibody-bound and free serum determination of a 14C-labeled Escherichia coli extract after single oral administration in rats.
    van Dijk A, Bauer J, Sedelmeier EA, Bessler WG.
    Arzneimittelforschung; 1997 Mar 01; 47(3):329-34. PubMed ID: 9105555
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic potential of benfotiamine and its molecular targets.
    Raj V, Ojha S, Howarth FC, Belur PD, Subramanya SB.
    Eur Rev Med Pharmacol Sci; 2018 May 01; 22(10):3261-3273. PubMed ID: 29863274
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W, Barth H, Becker R, Frankus E, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 May 01; 48(5):436-45. PubMed ID: 9638309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.